Endothelin a receptor antagonist reduces renal vasoconstriction induced by mechanical manipulation of renal artery

被引:0
|
作者
Watarai, Y [1 ]
Yoshioka, M [1 ]
Tanada, K [1 ]
Seki, T [1 ]
Saito, H [1 ]
Koyanagi, T [1 ]
机构
[1] Hokkaido Univ, Sch Med, Dept Urol, Sapporo, Hokkaido 0608638, Japan
关键词
endothelin; vasoconstriction; mechanical manipulation; endothelin A receptor;
D O I
10.1159/000030510
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The purpose of this study was to make a model of renal vasoconstriction induced by mechanical manipulation of the renal artery and to investigate the influence of endothelin (ET) in renal vasoconstriction. Renal arteries of anesthetized rats were stretched with a 30-gram weight for 5 min, and released. Renal blood flow (RBF) was monitored with a laser flowmeter. To determine the role of ET, a selective ETA receptor antagonist, BQ-123 (0.1 and 1 mg/kg) was administered into the aorta. The manipulation was invariably followed by a flow reduction of about 57% after temporary hyperemia. RBF returned to the basal level 5 min after the release. BQ-123 partially, but significantly, inhibited the mechanical manipulation-induced reduction of RBF in a dose-dependent manner. These results suggest that endogeneous ET may play an important role in renal vasoconstriction induced by mechanical manipulation of the renal artery. Copyright (C) 2000 S. Karger AG, Basel.
引用
收藏
页码:121 / 125
页数:5
相关论文
共 50 条
  • [21] Contribution of endothelin receptors in renal microvessels in acute cyclosporine-mediated vasoconstriction in rats
    Cavarape, A
    Endlich, K
    Feletto, F
    Parekh, N
    Bartoli, E
    Steinhausen, M
    KIDNEY INTERNATIONAL, 1998, 53 (04) : 963 - 969
  • [22] Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure - A comparison of selective and combined endothelin receptor blockade
    Goddard, J
    Johnston, NR
    Hand, MF
    Cumming, AD
    Rabelink, TJ
    Rankin, AJ
    Webb, DJ
    CIRCULATION, 2004, 109 (09) : 1186 - 1193
  • [23] Endothelin-A receptor antagonist combined with hydralazine improves survival and renal function in hypertensive rats
    Münter, K
    Hergenröder, S
    Kirchengast, M
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 : S245 - S248
  • [24] Prevention of cold ischaemia-reperfusion injury by an endothelin receptor antagonist in experimental renal transplantation
    Herrero, I
    Torras, J
    Riera, M
    Condom, E
    Coll, O
    Cruzado, JM
    Hueso, M
    Bover, J
    Lloberas, N
    Alsina, J
    Grinyó, JM
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (04) : 872 - 880
  • [25] Adenosine-induced renal vasoconstriction in man
    Marraccini, P
    Fedele, S
    Marzilli, M
    Orsini, E
    Dukic, G
    Serasini, L
    LAbbate, A
    CARDIOVASCULAR RESEARCH, 1996, 32 (05) : 949 - 953
  • [26] Blunted renal vasoconstriction in patients with subclinical contrast-induced renal injury
    Kurihara, Osamu
    Seino, Yoshihiko
    Shibata, Yusaku
    Matsushita, Masato
    Komiyama, Hidenori
    Kato, Katsuhito
    Murakami, Daisuke
    Munakata, Ryo
    Takano, Masamichi
    Miyauchi, Yasushi
    Hata, Noritake
    Shimizu, Wataru
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2016, 43 (11): : 1148 - 1150
  • [27] DIFFERENTIAL BLOCKADE OF THE RENAL VASOCONSTRICTOR AND DIURETIC RESPONSES TO ENDOTHELIN-1 BY ENDOTHELIN ANTAGONIST
    KAMPHUIS, C
    YATES, NA
    MCDOUGALL, JG
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1994, 21 (04) : 329 - 333
  • [28] EFFECT OF NIFEDIPINE ON CYCLOSPORINE A-INDUCED NEPHROTOXICITY, URINARY ENDOTHELIN EXCRETION AND RENAL ENDOTHELIN RECEPTOR NUMBER
    BROOKS, DP
    OHLSTEIN, EH
    CONTINO, LC
    STORER, B
    PULLEN, M
    CALTABIANO, M
    NAMBI, P
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 194 (01) : 115 - 117
  • [29] Renal, retinal and cardiac changes in type 2 diabetes are attenuated by macitentan, a dual endothelin receptor antagonist
    Sen, S.
    Chen, S.
    Feng, B.
    Iglarz, M.
    Chakrabarti, S.
    LIFE SCIENCES, 2012, 91 (13-14) : 658 - 668
  • [30] Therapeutic administration of an endothelin-A receptor antagonist after acute ischemic renal failure dose-dependently improves recovery of renal function
    Knoll, T
    Schult, S
    Birck, R
    Braun, C
    Michel, MS
    Bross, S
    Juenemann, KP
    Kirchengast, M
    Rohmeiss, P
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2001, 37 (04) : 483 - 488